Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
38
天
piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation
作者
Suyuelin Huang; Yuxiao Li; Yuchen Shi; Fenghao Zhang; Dingheng Lu; Kai Yu; Jiawei Zhang; Jihuan Yuan; Xiao Wang; Xueyou Ma; Jiangfeng Li; Jiazhu Sun; Ben Liu展开收起
作者单位
Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China展开收起
113
天
RNF34 restrains endometriosis progression by promoting PKM2 ubiquitination and suppressing glycolysis
作者
Jiayu Liu; Jie Zhang; Qiaozhu Wu; Chao Lu; Zhenhai Yu展开收起
作者单位
Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, PR China; School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, PR China展开收起
79
天
PREX1 regulates renal fibrosis through the RPTOR-mTORC1 signaling pathway
作者
Xiangyang Geng; Guang Chen; Yong Qian; Weimin Shan; Xiaowei Li; Jiehao Zhou; Xiao Wang展开收起
作者单位
Department of Urology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China; Department of Nephrology, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China; Department of Emergency Surgery, Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui 236012, China展开收起
81
天
DRAM1 activates microglial pyroptosis and neuroinflammation through TMEM9-mediated lysosomal membrane permeabilization after spinal cord injury
作者
Zhichao Xiong; Guangkui Yan; Jinfa Wu; Tiantain Xu; Jiangwei Chen; Jiaming Liu; Liuxue Du展开收起
作者单位
Department of Orthopedic Hospital, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China; Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Disease, Nanchang 330006, China; Department of Pharmacy, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China展开收起
105
天
Low-dose polysaccharides exert dual redox effects via the ROS-mediated MAPK pathway: Antioxidant alone or pro-oxidant when GLP is combined with doxorubicin in A2780 ovarian cancer cells
作者
Yuqian Zhang; Xinru Li; Yutong Shen; Lijuan Yang; Min Yang; Xiaona Meng; Bandar Al-Hamyari; Yongyan Shi; Shengnan Meng展开收起
作者单位
Department of Pharmaceutics, School of Pharmacy, China Medical University, Shenyang 110122, China; Department of Pediatrics, Shengjing Hospital of China Medical University, National Center for Children's Health, Shenyang 110004, China展开收起
92
天
miR-138-5p suppresses M2 macrophage polarization in esophageal squamous cell carcinoma via exosomes
作者
Wei Xu; Yang Chen; Fei Teng; Shengwei Li; Zhiqiang Wang展开收起
作者单位
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China; Department of Thoracic Surgery, Chongqing University Cancer Hospital, Chongqing 400030, China展开收起
FAQ
CELLULAR SIGNALLING审稿要多久?
截至2026-11-19,CrushSCI 收录了 CELLULAR SIGNALLING 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 38 天(piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation,2026-09-19 收稿,2026-10-27 录用),最慢一篇用了 201 天;平均 104.8 天,中位数 104.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
